Stay updated on IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s interface release/version stamp is updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a software/template update without changing the underlying trial information.
    Difference
    0.1%
    Check dated 2026-04-24T06:17:25.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:38:06.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:48:54.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:44:30.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    An addition of Revision: v3.4.2 and a deletion of Revision: v3.4.1 were made in the page's revision history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T14:23:01.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; there are no changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T10:32:56.000Z thumbnail image

Stay in the know with updates to IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.